1. |
中华医学会肾脏病学分会专家组. 抗中性粒细胞胞质抗体相关肾炎诊断和治疗中国指南. 中华肾脏病杂志, 2021, 37(7): 603-620.
|
2. |
Mukhtyar C, Lee R, Brown D, et al. Modification and validation of the Birmingham Vasculitis Activity Score (version 3). Ann Rheum Dis, 2009, 68(12): 1827-1832.
|
3. |
Karras A, Lazareth H, Chauvet S. B-cell treatment in ANCA-associated vasculitis. Rheumatology (Oxford), 2020, 59(Suppl 3): iii68-iii73.
|
4. |
Cortazar FB, Muhsin SA, Pendergraft WF 3rd, et al. Combination therapy with rituximab and cyclophosphamide for remission induction in ANCA vasculitis. Kidney Int Rep, 2017, 3(2): 394-402.
|
5. |
Kidney Disease: Improving Global Outcomes (KDIGO) ANCA Vasculitis Work Group. KDIGO 2024 clinical practice guideline for the management of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. Kidney Int, 2024, 105(3S): S71-S116.
|
6. |
Connelly-Smith L, Alquist CR, Aqui NA, et al. Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the Writing Committee of the American Society for Apheresis: the ninth special issue. J Clin Apher, 2023, 38(2): 77-278.
|
7. |
Cheng L, Tang YQ, Yi J, et al. Double filtration plasmapheresis in the treatment of anti-neutrophil cytoplasmic antibody-associated vasculitis with severe kidney dysfunction. Blood Purif, 2020, 49(6): 713-722.
|
8. |
程芝灵, 孙桂香, 林辉, 等. 血浆置换治疗肝衰竭临床疗效和安全性的 Meta 分析. 中国循证医学杂志, 2015, 15(6): 664-671.
|
9. |
Liu JF, Wang WX, Xue J, et al. Comparing the autoantibody levels and clinical efficacy of double filtration plasmapheresis, immunoadsorption, and intravenous immunoglobulin for the treatment of late on set myasthenia gravis. Ther Apher Dial, 2010, 14(2): 153-160.
|
10. |
Zhang YY, Tang Z, Chen DM, et al. Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis. BMC Nephrol, 2014, 15: 128.
|
11. |
Winters JL. Apheresis in the treatment of idiopathic dilated cardiomyopathy. J Clin Apher, 2012, 27(6): 312-319.
|
12. |
Stegmayr BG, Almroth G, Berlin G, et al. Plasma exchange or immunoadsorption in patients with rapidly progressive crescentic glomerulonephritis. A Swedish multi-center study. Int J Artif Organs, 1999, 22(2): 81-87.
|
13. |
Maillard N, Absi L, Claisse G, et al. Protein A-based immunoadsorption is more efficient than conventional plasma exchange to remove circulating anti-HLA antibodies. Blood Purif, 2015, 40(2): 167-172.
|
14. |
杜云英, 张旭峰, 陈校园, 等. 重组蛋白 A 免疫吸附剂的制备及吸附性能. 北京化工大学学报(自然版), 2011, 38(3): 92-96.
|